What the Numbers Don't Tell You As your physician, I have to point out what raw weight-loss percentages leave out: Both Medications Produce Clinically Meaningful Results A 13.7% weight loss with semaglutide is transformative for most patients
Results showed berberine reduced body weight by 2.05 kg (approximately 4.5 pounds) and BMI by 1.04 kg/m compared to placebo or lifestyle intervention alone
M.MysoreV
In the 3xtg mouse model of AD, which expresses human mutated genes of APP, PS1, and tau, it was found that spatial memory was rescued by DA4-JC

Pre-Research Assessment: Complete medical history and physical review Baseline blood glucose and HbA1c Liver function tests (ALT, AST, bilirubin) Renal function tests (creatinine, BUN, eGFR) Complete blood count Lipid panel IGF-1 and IGFBP-3 levels Thyroid function tests Screening for contraindications During Research Tracking: Regular blood glucose tracking (frequency based on dose and risk factors) Periodic assessment of liver and renal function Tracking for signs of fluid retention Assessment of injection sites Records of any adverse findings Regular evaluation of research parameters Post-Research Assessment: Repeat baseline laboratory tests Evaluation of any persistent effects Assessment of research outcomes Planning of appropriate follow-up Managing Adverse Observations Research protocols should include plans for managing possible adverse findings
Current Obesity Reports, 12(2), 6174